Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by Sarb99on Jan 04, 2021 7:17pm
157 Views
Post# 32220837

RE:RE:RE:RE:QuestCap Announces C$5M Bought Deal Led by Canaccord Genuity

RE:RE:RE:RE:QuestCap Announces C$5M Bought Deal Led by Canaccord Genuity
I think they still need to make a payment for investment in Sunnybrook Research Institute, Sinai Health System and Amino Therapeutics. 
 
Whenever any brokerage initiates research coverage, they always want something in return. So getting free shares are illegal, and a private placement probably is legal. 
 
Also, If anyone watched trading from the last week, Canaccord is the one who started buying on December 29th. Before that, QSC was trading at .25 to.28 cents. Hopefully, in return for these shares, Canaccord can bring big investors buying MEDV.  

TotalCorruption wrote: Obviously the sp couldn't be at .50 plus as it was and would have gone higher ! Dirty trick! Raise $ at half the sp. embarrassing. Gave it away. Way better places than Cannacrap to go for $ with a legit & promising business model as this. Not at all impressed.


<< Previous
Bullboard Posts
Next >>